Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Once Daily and Twice Daily in Subjects With Primary Open-Angle Glaucoma SPECTRUM 6

NCT03858894 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Open-angle Glaucoma and Ocular Hypertension

Interventions

DRUG: DE-117 Ophthalmic Solution QD
DRUG: DE-117 Ophthalmic Solution BID

Sponsor

Santen Inc.